Answers are grounded in this paper and cite their sources.
Phototherapy with the properties of specific spatial/temporal selectivity and minimal invasiveness has been acknowledged as one of the most promising cancer therapy types. Among all the photoactive substance for phototherapy, titanium dioxide (TiO 2 ) nanomaterials are paid more and more attention due to their outstanding photocatalytic properties, prominent biocompatibility, and excellent chemical stability. However, the wide bandgap (3.0–3.2 eV) of TiO 2 limits its absorption only to the ultraviolet (UV) light region. For a long time, UV light–stimulated TiO 2 was applied in the phototherapy researches of tumors located in the skin layer, while it is unsatisfactory for most deep‐tissue tumors. Due to the maximum penetration into tissue existing in the near‐infrared (NIR) region, how to use NIR light to trigger photochemical reaction of TiO 2 remains a big challenge. In this review, two strategies to develop and construct NIR‐triggered TiO 2 ‐based nanocomposites (NCs) for phototherapy are summarized, and the relevant mechanism and background knowledge of TiO 2 ‐based phototherapy are also given in order to better understand the application value and current situation of TiO 2 in phototherapy. Finally, the challenges and research directions of TiO 2 in the future clinic phototherapy application are also discussed.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: